Matica Enterprises subsidiary RoyalMax Biotechnology Canada has received approval to supply cannabis from the Saskatchewan Liquor and Gaming Authority (SLGA), the provincial regulator responsible for permitting and monitoring the operation of local cannabis wholesalers and retailers in the Province.
“We are excited that Saskatchewan will be the first province to try our premium Montreal cannabis,” says Matica CEO Boris Ziger. “In short order we will be opening up sales in other provinces as well.”
"This a major milestone for Matica and RoyalMax. The Company is completing its transition to a commercial, revenue generating enterprise. Generating revenue and profits for our shareholders is a priority for management at this time, as is growth. Over the coming months, we will be re-evaluating projects and introducing new ones. Please go to Matica’s website for more news and follow us on Twitter for articles and updates."
The Company has granted 10,250,000 stock options including 9,000,000 to one consultant and two directors, which included reissuing of 7,000,000 million previously cancelled options. A further 1,250,000 were granted to three consultants. All granted options are exercisable at $0.025 for up to five years from the date of grant. Further, the Company has cancelled 3,000,000 previous granted management stock options.
For more information:
Matica Enterprises
maticaenterprises.com